Latest filing published 26 Jul 2022 for Assembly Biosciences, INC., €4,381.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Michael P. Samar: trading record in brief
Michael P. Samar (finance chief) discloses dealings in Assembly Biosciences, Inc. to SEC (Form 4). Over a trading history stretching from 1 October 2019 to 25 July 2022, the count stands at 5 filings.
Sales make up the whole of the open-market record (2 sales, €8,823). The rest of the record consists of 3 share grants. Since January 2022: no purchases and 2 sales on the market.
The newest entry dates from 26 July 2022: an open-market sale of €4,381, in Assembly Biosciences, Inc. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Michael P. Samar
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,020 shares@ US$2.2174100.0% of flowCommon StockSEC:0001209191-22-043216:0
- 26,250 shares0Common StockSEC:0001209191-22-021781:0
- 10,938 shares0Common StockSEC:0001209191-21-047818:0
3 of 3 declarations